Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Induced pluripotent stem cell technology for the study of human disease.

Literature DB >> 20038952

Induced pluripotent stem cell technology for the study of human disease.

Gabsang Lee¹, Lorenz Studer.

Abstract

Entities: Species

Mesh：

Year: 2010 PMID： 20038952 DOI： 10.1038/nmeth.f.283

Source DB: PubMed Journal: Nat Methods ISSN： 1548-7091 Impact factor: 28.547

× No keyword cloud information.

24 in total

1. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

Authors: Lan Kang; Jianle Wang; Yu Zhang; Zhaohui Kou; Shaorong Gao
Journal: Cell Stem Cell Date: 2009-07-23 Impact factor: 24.633

2. Viable offspring derived from fetal and adult mammalian cells.

Authors: I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal: Nature Date: 1997-02-27 Impact factor: 49.962

3. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

Authors: Makiko Nagai; Diane B Re; Tetsuya Nagata; Alcmène Chalazonitis; Thomas M Jessell; Hynek Wichterle; Serge Przedborski
Journal: Nat Neurosci Date: 2007-04-15 Impact factor: 24.884

4. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors: Kazutoshi Takahashi; Shinya Yamanaka
Journal: Cell Date: 2006-08-10 Impact factor: 41.582

5. Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors: Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal: Nature Date: 2008-12-21 Impact factor: 49.962

6. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors: Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal: Nature Date: 2009-05-31 Impact factor: 49.962

7. Generation of germline-competent induced pluripotent stem cells.

Authors: Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal: Nature Date: 2007-06-06 Impact factor: 49.962

8. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors: Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal: Nature Date: 2007-06-06 Impact factor: 49.962

9. iPS cells produce viable mice through tetraploid complementation.

Authors: Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal: Nature Date: 2009-09-03 Impact factor: 49.962

10. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors: Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal: Nature Date: 2009-08-19 Impact factor: 49.962

25 in total

1. Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells.

Authors: Laura Menendez; Tatiana A Yatskievych; Parker B Antin; Stephen Dalton
Journal: Proc Natl Acad Sci U S A Date: 2011-11-14 Impact factor: 11.205

Induced pluripotent stem cell technology for the study of human disease.

1. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

2. Viable offspring derived from fetal and adult mammalian cells.

3. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

4. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

5. Induced pluripotent stem cells from a spinal muscular atrophy patient.

6. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

7. Generation of germline-competent induced pluripotent stem cells.

8. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

9. iPS cells produce viable mice through tetraploid complementation.

10. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

1. Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells.

Review 2. Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System.

3. Modelling familial dysautonomia in human induced pluripotent stem cells.

Review 4. Annual Research Review: The promise of stem cell research for neuropsychiatric disorders.

Review 5. Present state and future perspectives of using pluripotent stem cells in toxicology research.

6. Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells.

Review 7. Approaches to characterize the transcriptional trajectory of human myogenesis.

8. Human Pluripotent Stem Cell Differentiation to Microglia.

9. Feeder-free derivation of neural crest progenitor cells from human pluripotent stem cells.

Review 10. Pluripotent Stem Cell Platforms for Drug Discovery.